FAQs
Most frequent questions and answers
TriNetra™ detects ‘existence of cancer’.
TriNetra™ is not intended to be and should not be considered as a substitute for any recommended screening methods.
Within the limits of error, a ‘negative’ result is an indication of undetectable cancer at the time of the test. For other cancers not covered by the test, no inference should be drawn from a ‘negative’ result.
A ‘negative’ result means that at the time of the test there were no detectable cancer cells suggestive of cancer circulating in the blood. TriNetra™ is recommended to be performed annually.
As TriNetra™ is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that TriNetra™ should be performed every 12 months.
The test indicates the organ affected by cancer with high accuracy in most types of cancers / cases. In all cases of ‘positive’ results, the Report should be interpreted by your physician who can guide you on the further course of action.
No, such individuals should seek expert medical advice without delay.